126 related articles for article (PubMed ID: 36519190)
21. Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A.
Li Y; Golden JB; Camhi MI; Zhang X; Fritz Y; Diaconu D; Ivanco TL; Simon DI; Kikly K; McCormick TS; Wang Y; Ward NL
J Invest Dermatol; 2018 Feb; 138(2):310-315. PubMed ID: 28951241
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
23. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.
Sugiyama H; Gyulai R; Toichi E; Garaczi E; Shimada S; Stevens SR; McCormick TS; Cooper KD
J Immunol; 2005 Jan; 174(1):164-73. PubMed ID: 15611238
[TBL] [Abstract][Full Text] [Related]
24. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
[TBL] [Abstract][Full Text] [Related]
25. Serum concentration of osteopontin and interleukin 17 in psoriatic patients.
Przepiórka-Kosińska JM; Bartosińska J; Raczkiewicz D; Bojar I; Kosiński J; Krasowska D; Chodorowska G
Adv Clin Exp Med; 2020 Feb; 29(2):203-208. PubMed ID: 32109010
[TBL] [Abstract][Full Text] [Related]
26. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
27. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Br J Dermatol; 2010 Dec; 163(6):1282-90. PubMed ID: 20716219
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis.
Alvarez P; Augustín JJ; Tamayo E; Iglesias M; Acinas O; Mendiguren MA; Vázquez JA; Genre F; San Segundo D; Merino J; Merino R
Arthritis Rheumatol; 2020 Sep; 72(9):1547-1558. PubMed ID: 32249544
[TBL] [Abstract][Full Text] [Related]
29. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway.
Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.
Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY
Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of regulatory molecules in the skin of psoriasis.
Sabag AD; Dias-Polak D; Bejar J; Sheffer H; Bergman R; Vadasz Z
Immunol Res; 2018 Dec; 66(6):649-654. PubMed ID: 30613859
[TBL] [Abstract][Full Text] [Related]
32. IL-23 induces atopic dermatitis-like inflammation instead of psoriasis-like inflammation in CCR2-deficient mice.
Bromley SK; Larson RP; Ziegler SF; Luster AD
PLoS One; 2013; 8(3):e58196. PubMed ID: 23472158
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
[TBL] [Abstract][Full Text] [Related]
34. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Mitra A; Raychaudhuri SK; Raychaudhuri SP
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
[TBL] [Abstract][Full Text] [Related]
35. Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis.
Vandeghinste N; Klattig J; Jagerschmidt C; Lavazais S; Marsais F; Haas JD; Auberval M; Lauffer F; Moran T; Ongenaert M; Van Balen M; Dupont S; Lepescheux L; Garcia T; Härtle S; Eyerich K; Fallon PG; Brys R; Steidl S
J Invest Dermatol; 2018 Jul; 138(7):1555-1563. PubMed ID: 29474945
[TBL] [Abstract][Full Text] [Related]
36. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261
[TBL] [Abstract][Full Text] [Related]
37. Characterization of psoriasiform dermatitis induced by systemic injection of interleukin-23 minicircles in mice.
Leys L; Wang Y; Paulsboe S; Edelmayer R; Salte K; Wetter J; Namovic M; Phillips L; Dunstan R; Gauvin D; Donnelly-Roberts D; Su Z; Honore P; McGaraughty S
J Dermatol; 2019 Jun; 46(6):482-497. PubMed ID: 31062408
[TBL] [Abstract][Full Text] [Related]
38. Expression of T-helper 17 cells and signal transducers in patients with psoriasis vulgaris of blood-heat syndrome and blood-stasis syndrome.
Fan B; Li X; Ze K; Xu R; Shi RF; Geng L; Li FL; Wang YF; Chen J; Li B
Chin J Integr Med; 2015 Jan; 21(1):10-6. PubMed ID: 25246139
[TBL] [Abstract][Full Text] [Related]
39. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
Johansen C; Funding AT; Otkjaer K; Kragballe K; Jensen UB; Madsen M; Binderup L; Skak-Nielsen T; Fjording MS; Iversen L
J Immunol; 2006 Feb; 176(3):1431-8. PubMed ID: 16424170
[TBL] [Abstract][Full Text] [Related]
40. Oral Administration of Vanillin Improves Imiquimod-Induced Psoriatic Skin Inflammation in Mice.
Cheng HM; Chen FY; Li CC; Lo HY; Liao YF; Ho TY; Hsiang CY
J Agric Food Chem; 2017 Nov; 65(47):10233-10242. PubMed ID: 29073354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
